肺结核化疗依从性影响因素研究  

Evaluation of treatment adherence for patient with tuberculosis based chemotherapy

作　　者：刘亚非[1] 马海英[1] 

机构地区：[1]中国医科大学附属第四医院药学部,辽宁沈阳110032

出　　处：《实用临床医药杂志》2011年第7期96-97,102,共3页Journal of Clinical Medicine in Practice

摘　　要：目的应用生存分析统计技术评价肺结核患者化疗依从性。方法观察两组患者的转归分布情况、退出治疗原因,并利用生存分析统计技术中统计两组患者累计治疗时间达到1、2、3、4、5、6和7个月的坚持治疗率及中位治疗时间。结果 6个月末的坚特治疗率初治患者为43.76%,复治患者为26.32%。中位坚持治疗时间初治患者为4.677 4个月,复治患者为3 167 2个月。在治疗初期和晚期坚持治疗率下降较快。结论结恢患者的用药教育应侧重于治疗初期和晚期,以及复治患者。Objective To evaluate the treatment adherence for patients with tuberculosis survival analysis based method.Methods The prognosis of patients distribution and the reasons for withdrawal treatment in the two groups were observed.The rate of adherence to treatment and median time of treatment in January,February,March,April,May,June and July were analyzed by survival analysis techniques in the two groups.Results The rate of adherence to treatment was 43.76%in untreated patients and 26.32%in retreated patients at the end of June.The median time of treatment was 4.677 4 months in untreated patients and 3.167 2 months in retreated patients.In the treatment of early and late stages,treatment adherence rate decreased rapidly.Conclusion Tuberculosis medication education should focus on the treatment of early and late stages,and re -treated patients.

关 键 词：肺结核 生存分析 依从性 

分 类 号：R521[医药卫生—内科学]